John Dangerfield Ph.d.
Director,
Chief Executive Officer
Anovasia
Australia
Biography
Originally from the UK, John completed his PhD in molecular biology in Vienna in 2001. After a further 6 years in Austria doing fundamental research with viral vectors and bionanotechnology for cancer, he side-stepped into the biomedical industry in 2007 as Head of Laboratory for Austrianova Singapore Pte Ltd (part of the SG Austria Group), a company based within Singapore’s main biotechnology hub, the Biopolis. In 2011 he co-founded Anovasia Pte Ltd. In addition to his role at Anovasia, John remains with Austrianova as Chief Operating Officer (since 2010) where as well as operational activities he is also involved in business development and fund raising. John was an active Council Member for the bio-industry alliance organisation BioSingapore from 2011-2014 and is currently acting as advisor to support the Singapore Stem Cell Consortium. John has co-authored 16 peer-reviewed journal articles, 3 book chapters, has edited two books. He is also inventor on 5 patents and patent applications and has procured a significant number of academic and industry grants.
Research Interest
Molecular Biology and Molecular genetics
